{
    "clinical_study": {
        "@rank": "139735", 
        "arm_group": [
            {
                "arm_group_label": "control", 
                "description": "Healthy people from community and physical examination centers are recruited as controls."
            }, 
            {
                "arm_group_label": "CKD1", 
                "description": "with clinical one or more symptoms and signs of kidney injury listed as below\uff1a\nUrinary albumin ( urinary albumin excretion rate\u226530 mg/24 h.albumin-creatinine ratio\u22653mg/mmol)\nurinary sediments abnormality\nrenal tubular lesions\nrenal histological abnormalities\nabnormal structure showed by imaging\nhistory of renal transplantation\nGFR\u226590\uff08ml/min/1.73m\u00b2)"
            }, 
            {
                "arm_group_label": "CKD2", 
                "description": "with clinical symptoms and signs of kidney injury, and 60<=GFR<=89\uff08ml/min/1.73m\u00b2)"
            }, 
            {
                "arm_group_label": "CKD3", 
                "description": "with clinical symptoms and signs of kidney injury, and 30<=GFR<=59\uff08ml/min/1.73m\u00b2)"
            }, 
            {
                "arm_group_label": "CKD4", 
                "description": "with clinical symptoms and signs of kidney injury, and 15<=GFR<=29\uff08ml/min/1.73m\u00b2)"
            }, 
            {
                "arm_group_label": "CKD5", 
                "description": "with clinical symptoms and signs of kidney injury, and GFR<15\uff08ml/min/1.73m\u00b2)"
            }
        ], 
        "biospec_descr": {
            "textblock": "Serum and plasma of cases and controls"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Patients with chronic renal insufficiency usually develop secondary osteoporosis or bone\n      loss, which is called renal osteodystrophy. Most of the previous studies focused on bone\n      metabolism of patients in late stage of chronic renal insufficiency, especially those with\n      chronic dialysis. In this study, bone metabolism of patients in different stages of chronic\n      renal insufficiency will be observed to reveal the mechanism of development of renal\n      osteodystrophy and provide clues for early intervention on renal osteodystrophy."
        }, 
        "brief_title": "Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency", 
        "condition": [
            "Chronic Renal Insufficiency", 
            "Renal Osteodystrophy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Kidney Failure, Chronic", 
                "Renal Insufficiency, Chronic", 
                "Renal Insufficiency", 
                "Renal Osteodystrophy"
            ]
        }, 
        "detailed_description": {
            "textblock": "In this study, patients with chronic renal insufficiency (CKD1-5, defined by glomerular\n      filtration rate\uff0cGFR) and healthy people as control will be recruited (50/group, total 300).\n      Blood urea nitrogen, creatinine,lumbar and hip bone mineral density, bone turnover\n      biochemical markers including serum total propeptide of type I procollagen\uff08PINP\uff09, bone\n      alkaline phosphatase\uff08BALP\uff09, bone Gla-protein (BGP) and \u03b2-CrOSSlaps\uff08\u03b2-CTX\uff09, serum calcium and\n      phosphorus and related regulators including fibroblast growth factor 23 (FGF23),\n      25-hydroxyl-Vitamin D \uff0825-OH-VitD\uff09, parathyroid hormone\uff08PTH\uff09 will be detected. The\n      relationship between kidney function and bone turnover, and the rules throughout the\n      development process of renal osteodystrophy will be analysed.The micro\n      ribonucleotide\uff08miRNA\uff09array will also be performed to screen the biomarkers of renal\n      osteodystrophy in different stage."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. 20-50 years old\n\n          2. chronic renal insufficiency (Control: normal kidney function; Case: CKD 1-5)\n\n          3. be willing to and be able to join in the study and signed informed consent\n\n          4. have not accepted systematical treatment on bone loss or osteoporosis\n\n        Exclusion Criteria:\n\n          1. allergies\n\n          2. secondary osteoporosis caused by other diseases.\n\n          3. postmenopausal women\n\n          4. mental illness or psychosis\n\n          5. patients with bone fracture and need surgery treatment\n\n          6. taking any medicine that will affect bone metabolism for a long time and can not stop\n\n          7. women during pregnant stage and breast-feed stage"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Cases groups (CKD-5) are recruited from inpatients and outpatients in the 4 centers.\n\n        Controls are recruited from community samples and physical examination population."
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02147782", 
            "org_study_id": "Renal Osteodystrophy", 
            "secondary_id": "1RT1270,2010CB530400"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function", 
        "lastchanged_date": "May 22, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Shunjin Hu", 
                    "phone": "0551-62838661"
                }, 
                "facility": {
                    "address": {
                        "city": "Hefei", 
                        "country": "China", 
                        "state": "Anhui", 
                        "zip": "230031"
                    }, 
                    "name": "Anhui Province Hospital of TCM"
                }, 
                "investigator": {
                    "last_name": "Shunjin Hu", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China", 
                        "state": "Jiangsu"
                    }, 
                    "name": "Jiangsu Province Hospital of TCM"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "lixiaofeng0409@163.com", 
                    "last_name": "Xiaofeng Li, PhD", 
                    "phone": "86-21-64395700"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200032"
                    }, 
                    "name": "Longhua hospital affiliated to Shanghai University of TCM"
                }, 
                "investigator": {
                    "last_name": "Xiaofeng Li", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Xu Zhang", 
                    "phone": "62483180"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200040"
                    }, 
                    "name": "Huadong Hospital Affiliated to Fudan University"
                }, 
                "investigator": {
                    "last_name": "Xu Zhang", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "6", 
        "official_title": "Continuous Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency in Different Stages", 
        "other_outcome": {
            "measure": "Baseline information \uff08height, weight, sex\uff09", 
            "safety_issue": "No", 
            "time_frame": "1 day after enrollment"
        }, 
        "overall_contact": {
            "email": "yjwang88@hotmail.com", 
            "last_name": "Yongjun Wang, MD,PhD", 
            "phone": "86-21-64385700"
        }, 
        "overall_contact_backup": {
            "email": "shubing523@hotmail.com", 
            "last_name": "Bing Shu, PhD", 
            "phone": "86-21-64386239"
        }, 
        "overall_official": {
            "affiliation": "Shanhgai University of TCM", 
            "last_name": "Yongjun Wang, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China:Shanghai Municipal Commission of Health and Family Planning", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "lumbar (L1-4 as well as total) and hip (neck, troch, inter and word's) bone mineral density will be recorded by dual energy X-ray absorptiometry. Serum bone turnover biomarkers including total PINP, BGP, BALP and \u03b2-CTx will be detected.", 
            "measure": "bone metabolism (bone mineral density and serum bone turnover biomarkers)", 
            "safety_issue": "No", 
            "time_frame": "1 day after enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02147782"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shanghai University of Traditional Chinese Medicine", 
            "investigator_full_name": "Bing Shu", 
            "investigator_title": "Research Asistant", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "CKD1-5 will be graded by glomerular filtration rate,and blood creatinine and urea nitrogen will be detected.", 
                "measure": "Kidney function \uff08blood creatinine and urea nitrogen,glomerular filtration rate\uff09", 
                "safety_issue": "No", 
                "time_frame": "1 day after enrollment"
            }, 
            {
                "description": "Serum calcium and phosphorus will be detected and the calcium-phosphorus product will be calculated.Factors which are related with calcium and phosphorus including FGF23, PTH and 25-OH-VitD will be detected.", 
                "measure": "Calcium and phosphorus metabolism (serum calcium and phosphorus,calcium-phosphorus product, FGF23, PTH and 25-OH-VitD)", 
                "safety_issue": "No", 
                "time_frame": "1 day after  enrollment"
            }, 
            {
                "description": "Blood plasma will be collected for microRNA array analysis to find specific biomarkers for each stage.We will also try to find biomarkers for better definitions of chronic renal insufficiency and renal osteodystrophy.", 
                "measure": "MicroRNA array", 
                "safety_issue": "No", 
                "time_frame": "1 day after enrollment"
            }
        ], 
        "source": "Shanghai University of Traditional Chinese Medicine", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Jiangsu province hospital of TCM", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Anhui Province Hospital of TCM", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Fudan University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Shanghai University of Traditional Chinese Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Day", 
        "verification_date": "May 2014"
    }
}